Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetes View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1989-05

AUTHORS

L. Al-Sakkaf, P. Pozzilli, A. C. Tarn, G. Schwarz, E. A. M. Gale, G. F. Bottazzo

ABSTRACT

Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction. More... »

PAGES

322-325

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00265550

DOI

http://dx.doi.org/10.1007/bf00265550

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1030608473

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2502462


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antigens, Differentiation, T-Lymphocyte", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD8 Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Follow-Up Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lymphocyte Activation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prediabetic State", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "T-Lymphocytes", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "St Bartholomew's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416353.6", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK", 
            "St. Martins Hospitals, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Al-Sakkaf", 
        "givenName": "L.", 
        "id": "sg:person.0676130551.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676130551.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sapienza University of Rome", 
          "id": "https://www.grid.ac/institutes/grid.7841.a", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK", 
            "Cattedra di Endocrinologia, University of Rome, La Sapienza, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pozzilli", 
        "givenName": "P.", 
        "id": "sg:person.0576452551.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576452551.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St Bartholomew's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416353.6", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tarn", 
        "givenName": "A. C.", 
        "id": "sg:person.0744243751.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744243751.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St Bartholomew's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416353.6", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schwarz", 
        "givenName": "G.", 
        "id": "sg:person.010353225202.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010353225202.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "St Bartholomew's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416353.6", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gale", 
        "givenName": "E. A. M.", 
        "id": "sg:person.012062434302.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012062434302.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Warwick", 
          "id": "https://www.grid.ac/institutes/grid.7372.1", 
          "name": [
            "Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK", 
            "Department of Immunology, The University College and Middlesex School of Medicine, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bottazzo", 
        "givenName": "G. F.", 
        "id": "sg:person.0723572726.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723572726.20"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00275749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002687211", 
          "https://doi.org/10.1007/bf00275749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002687211", 
          "https://doi.org/10.1007/bf00275749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275749", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002687211", 
          "https://doi.org/10.1007/bf00275749"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008198878", 
          "https://doi.org/10.1007/bf00275670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008198878", 
          "https://doi.org/10.1007/bf00275670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00275670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008198878", 
          "https://doi.org/10.1007/bf00275670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00274217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015008654", 
          "https://doi.org/10.1007/bf00274217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00274217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015008654", 
          "https://doi.org/10.1007/bf00274217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00274217", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015008654", 
          "https://doi.org/10.1007/bf00274217"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0092-8674(80)90072-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022873164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.32.1.91", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023059950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.294.6568.342", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034219379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.33.4.319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070734529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/diab.35.12.1416", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070734960"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078813515", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1989-05", 
    "datePublishedReg": "1989-05-01", 
    "description": "Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00265550", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "name": "Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetes", 
    "pagination": "322-325", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "91d0873a91bfa9abf8e7329177b7a7d653085251075fe55c30f6d05753393e5a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2502462"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0006777"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00265550"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1030608473"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00265550", 
      "https://app.dimensions.ai/details/publication/pub.1030608473"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130797_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2FBF00265550"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00265550'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00265550'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00265550'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00265550'


 

This table displays all metadata directly associated to this object as RDF triples.

182 TRIPLES      21 PREDICATES      48 URIs      31 LITERALS      19 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00265550 schema:about N0962dfd94a154bb886ab6ed292e0e3fd
2 N0fac0d9a81604653ad81d09e46437a17
3 N1af2d2ef61154618af4de0352c258241
4 N29b1147a2904470b99b7b3d1f9e11015
5 N2d47b39289b24b0eb7159a1dcb2618f4
6 N2eb6b543b93a44238610dbe5b3a6bdc2
7 N32fb4716ef86473c8e737002d40ede53
8 N55e4a1c85c3e476a859ad5dfaedddc5a
9 Ndbfc06d1910342efa37831c7f415768d
10 Ndd3b5764b6684384bfabb6fc3bd9c67f
11 anzsrc-for:11
12 anzsrc-for:1107
13 schema:author N86258cf9a41240a0878c226f421c68cd
14 schema:citation sg:pub.10.1007/bf00274217
15 sg:pub.10.1007/bf00275670
16 sg:pub.10.1007/bf00275749
17 https://app.dimensions.ai/details/publication/pub.1078813515
18 https://doi.org/10.1016/0092-8674(80)90072-0
19 https://doi.org/10.1136/bmj.294.6568.342
20 https://doi.org/10.2337/diab.32.1.91
21 https://doi.org/10.2337/diab.33.4.319
22 https://doi.org/10.2337/diab.35.12.1416
23 schema:datePublished 1989-05
24 schema:datePublishedReg 1989-05-01
25 schema:description Over a period of 5 years, lymphocyte subpopulations and their markers of activation were studied prospectively in 56 first degree relatives of Type 1 (insulin-dependent) diabetic probands. Lymphocytes were phenotyped using a panel of monoclonal antibodies which recognise CD3, CD4, CD8 lymphocytes, K/NK cells, HLA Class II products and IL-2 receptors (IL-2r). Twenty-six subjects were negative for islet cell antibody (ICA), 18 had complement fixing ICA (CF-ICA) and 12 only conventional ICA (ICA-IgG). The total number of observations (blood samples collected) was 386. Overall, changes in T cell data were observed in the three groups of first degree relatives compared to 70 normal subjects without a family history of diabetes. Six individuals developed Type 1 diabetes in the course of the study. They all possessed CF-ICA and five out of six showed a persistent reduction (less than 1.5) of the CD4/CD8 lymphocyte ratio before the clinical onset of the disease. Activated lymphocytes were found on two occasions in two of these subjects. We conclude that imbalance of lymphocyte immunoregulatory subsets is present before the onset of Type 1 diabetes in susceptible individuals; the persistence of a reduced CD4/CD8 lymphocyte ratio may reflect the ongoing process leading to B-cell destruction.
26 schema:genre research_article
27 schema:inLanguage en
28 schema:isAccessibleForFree false
29 schema:isPartOf N23cad83f04aa4bdeb9efaabc9cb578d5
30 N9e643b70d14c4875979e05f731963d96
31 sg:journal.1001482
32 schema:name Persistent reduction of CD4/CD8 lymphocyte ratio amd cell activation before the onset of Type 1 (insulin-dependent) diabetes
33 schema:pagination 322-325
34 schema:productId N16b7c7e2dbda49799c2dd4d8525a8a34
35 N7eb6b42ad9ac4754a884456e68f9c69f
36 Ncdce0675a4e042119fa852a1b3148a40
37 Nf5bbee33a12f44f1b5a9fc6c20dbd9c7
38 Nfdef41148a8042edab2b2600332064fb
39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030608473
40 https://doi.org/10.1007/bf00265550
41 schema:sdDatePublished 2019-04-11T13:50
42 schema:sdLicense https://scigraph.springernature.com/explorer/license/
43 schema:sdPublisher N6f71f261fb3a4366892a3c400b7aed10
44 schema:url https://link.springer.com/10.1007%2FBF00265550
45 sgo:license sg:explorer/license/
46 sgo:sdDataset articles
47 rdf:type schema:ScholarlyArticle
48 N0962dfd94a154bb886ab6ed292e0e3fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
49 schema:name Follow-Up Studies
50 rdf:type schema:DefinedTerm
51 N0fac0d9a81604653ad81d09e46437a17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
52 schema:name Prediabetic State
53 rdf:type schema:DefinedTerm
54 N16b7c7e2dbda49799c2dd4d8525a8a34 schema:name pubmed_id
55 schema:value 2502462
56 rdf:type schema:PropertyValue
57 N1af2d2ef61154618af4de0352c258241 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Antigens, Differentiation, T-Lymphocyte
59 rdf:type schema:DefinedTerm
60 N23cad83f04aa4bdeb9efaabc9cb578d5 schema:volumeNumber 32
61 rdf:type schema:PublicationVolume
62 N29b1147a2904470b99b7b3d1f9e11015 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Prospective Studies
64 rdf:type schema:DefinedTerm
65 N2d47b39289b24b0eb7159a1dcb2618f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Phenotype
67 rdf:type schema:DefinedTerm
68 N2eb6b543b93a44238610dbe5b3a6bdc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Humans
70 rdf:type schema:DefinedTerm
71 N32fb4716ef86473c8e737002d40ede53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Lymphocyte Activation
73 rdf:type schema:DefinedTerm
74 N42d68b6136b240119f1523b9ec8f2166 rdf:first sg:person.010353225202.97
75 rdf:rest N9c441f5b0578406993785e1aab4071fc
76 N55e4a1c85c3e476a859ad5dfaedddc5a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name CD8 Antigens
78 rdf:type schema:DefinedTerm
79 N6f71f261fb3a4366892a3c400b7aed10 schema:name Springer Nature - SN SciGraph project
80 rdf:type schema:Organization
81 N7eb6b42ad9ac4754a884456e68f9c69f schema:name doi
82 schema:value 10.1007/bf00265550
83 rdf:type schema:PropertyValue
84 N861de1b335434bb2b230c6f23e917939 rdf:first sg:person.0744243751.78
85 rdf:rest N42d68b6136b240119f1523b9ec8f2166
86 N86258cf9a41240a0878c226f421c68cd rdf:first sg:person.0676130551.32
87 rdf:rest N9c30d65dbd674c36a8f0f9f3e36dfbaa
88 N9c30d65dbd674c36a8f0f9f3e36dfbaa rdf:first sg:person.0576452551.25
89 rdf:rest N861de1b335434bb2b230c6f23e917939
90 N9c441f5b0578406993785e1aab4071fc rdf:first sg:person.012062434302.19
91 rdf:rest Nd1bfc29bd7c54d078ae66c561cb4e729
92 N9e643b70d14c4875979e05f731963d96 schema:issueNumber 5
93 rdf:type schema:PublicationIssue
94 Ncdce0675a4e042119fa852a1b3148a40 schema:name readcube_id
95 schema:value 91d0873a91bfa9abf8e7329177b7a7d653085251075fe55c30f6d05753393e5a
96 rdf:type schema:PropertyValue
97 Nd1bfc29bd7c54d078ae66c561cb4e729 rdf:first sg:person.0723572726.20
98 rdf:rest rdf:nil
99 Ndbfc06d1910342efa37831c7f415768d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name T-Lymphocytes
101 rdf:type schema:DefinedTerm
102 Ndd3b5764b6684384bfabb6fc3bd9c67f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Diabetes Mellitus, Type 1
104 rdf:type schema:DefinedTerm
105 Nf5bbee33a12f44f1b5a9fc6c20dbd9c7 schema:name nlm_unique_id
106 schema:value 0006777
107 rdf:type schema:PropertyValue
108 Nfdef41148a8042edab2b2600332064fb schema:name dimensions_id
109 schema:value pub.1030608473
110 rdf:type schema:PropertyValue
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
115 schema:name Immunology
116 rdf:type schema:DefinedTerm
117 sg:journal.1001482 schema:issn 0012-186X
118 1432-0428
119 schema:name Diabetologia
120 rdf:type schema:Periodical
121 sg:person.010353225202.97 schema:affiliation https://www.grid.ac/institutes/grid.416353.6
122 schema:familyName Schwarz
123 schema:givenName G.
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010353225202.97
125 rdf:type schema:Person
126 sg:person.012062434302.19 schema:affiliation https://www.grid.ac/institutes/grid.416353.6
127 schema:familyName Gale
128 schema:givenName E. A. M.
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012062434302.19
130 rdf:type schema:Person
131 sg:person.0576452551.25 schema:affiliation https://www.grid.ac/institutes/grid.7841.a
132 schema:familyName Pozzilli
133 schema:givenName P.
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0576452551.25
135 rdf:type schema:Person
136 sg:person.0676130551.32 schema:affiliation https://www.grid.ac/institutes/grid.416353.6
137 schema:familyName Al-Sakkaf
138 schema:givenName L.
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676130551.32
140 rdf:type schema:Person
141 sg:person.0723572726.20 schema:affiliation https://www.grid.ac/institutes/grid.7372.1
142 schema:familyName Bottazzo
143 schema:givenName G. F.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0723572726.20
145 rdf:type schema:Person
146 sg:person.0744243751.78 schema:affiliation https://www.grid.ac/institutes/grid.416353.6
147 schema:familyName Tarn
148 schema:givenName A. C.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0744243751.78
150 rdf:type schema:Person
151 sg:pub.10.1007/bf00274217 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015008654
152 https://doi.org/10.1007/bf00274217
153 rdf:type schema:CreativeWork
154 sg:pub.10.1007/bf00275670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008198878
155 https://doi.org/10.1007/bf00275670
156 rdf:type schema:CreativeWork
157 sg:pub.10.1007/bf00275749 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002687211
158 https://doi.org/10.1007/bf00275749
159 rdf:type schema:CreativeWork
160 https://app.dimensions.ai/details/publication/pub.1078813515 schema:CreativeWork
161 https://doi.org/10.1016/0092-8674(80)90072-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022873164
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1136/bmj.294.6568.342 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034219379
164 rdf:type schema:CreativeWork
165 https://doi.org/10.2337/diab.32.1.91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023059950
166 rdf:type schema:CreativeWork
167 https://doi.org/10.2337/diab.33.4.319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070734529
168 rdf:type schema:CreativeWork
169 https://doi.org/10.2337/diab.35.12.1416 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070734960
170 rdf:type schema:CreativeWork
171 https://www.grid.ac/institutes/grid.416353.6 schema:alternateName St Bartholomew's Hospital
172 schema:name Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK
173 St. Martins Hospitals, London, UK
174 rdf:type schema:Organization
175 https://www.grid.ac/institutes/grid.7372.1 schema:alternateName University of Warwick
176 schema:name Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK
177 Department of Immunology, The University College and Middlesex School of Medicine, UK
178 rdf:type schema:Organization
179 https://www.grid.ac/institutes/grid.7841.a schema:alternateName Sapienza University of Rome
180 schema:name Cattedra di Endocrinologia, University of Rome, La Sapienza, Italy
181 Department of Diabetes and Immunogenetics, St. Bartholomew's Hospital, UK
182 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...